A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges
Mario Cazzola,1 Nicola Alexander Hanania,2 William MacNee,3 Katja Rüdell,4 Claire Hackford,4 Nihad Tamimi4 1University of Rome ‘Tor Vergata’, Department of Medicine of Systems, Unit of Respiratory Clinical Pharmacology, Rome, Italy; 2Section of Pulmonary, Critical Care...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | International Journal of COPD |
| Online Access: | http://www.dovepress.com/a-review-of-the-most-common-patient-reported-outcomes-in-copd-ndash-re-peer-reviewed-article-COPD |
| _version_ | 1811287584555401216 |
|---|---|
| author | Cazzola M Hanania NA MacNee W Rüdell K Hackford C Tamimi N |
| author_facet | Cazzola M Hanania NA MacNee W Rüdell K Hackford C Tamimi N |
| author_sort | Cazzola M |
| collection | DOAJ |
| description | Mario Cazzola,1 Nicola Alexander Hanania,2 William MacNee,3 Katja Rüdell,4 Claire Hackford,4 Nihad Tamimi4 1University of Rome ‘Tor Vergata’, Department of Medicine of Systems, Unit of Respiratory Clinical Pharmacology, Rome, Italy; 2Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA; 3University of Edinburgh/MRC Centre for Inflammation Research, The Queen’s Medical Research Institute, Edinburgh, United Kingdom; 4Patient Reported Outcome Center of Excellence, Global Market Access, Primary Care Business Unit, Pfizer, Tadworth, United Kingdom Abstract: Patient-reported outcome (PRO) measures that quantify disease impact have become important measures of outcome in COPD research and treatment. The objective of this literature review was to comprehensively evaluate psychometric properties of available PRO instruments and the ability of each of them to characterize pharmaceutical treatment effects from published clinical trial evidence. Identified in this study were several PRO measures, both those that have been used extensively in COPD clinical trials (St George’s Respiratory Questionnaire and Chronic Respiratory Questionnaire) and new instruments whose full value is still to be determined. This suggests a great need for more information about the patient experience of treatment benefit, but this also may pose challenges to researchers, clinicians, and other important stakeholders (eg, regulatory agencies, pharmaceutical companies) who develop new treatment entities and payers (including but not limited to health technology assessment agencies such as the National Institute for Health and Care Excellence and the Canadian Agency for Drugs and Technologies in Health). The purpose of this review is to enable researchers and clinicians to gain a broad overview of PRO measures in COPD by summarizing the value and purpose of these measures and by providing sufficient detail for interested audiences to determine which instrument may be the most suitable for evaluating a particular research purpose. Keywords: COPD, patient reported outcome, health related quality of life, quality of life, psychometric properties |
| first_indexed | 2024-04-13T03:21:14Z |
| format | Article |
| id | doaj.art-b5089e6db54b45fcae2fc90942b66058 |
| institution | Directory Open Access Journal |
| issn | 1178-2005 |
| language | English |
| last_indexed | 2024-04-13T03:21:14Z |
| publishDate | 2015-04-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of COPD |
| spelling | doaj.art-b5089e6db54b45fcae2fc90942b660582022-12-22T03:04:46ZengDove Medical PressInternational Journal of COPD1178-20052015-04-012015Issue 172573821183A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challengesCazzola MHanania NAMacNee WRüdell KHackford CTamimi NMario Cazzola,1 Nicola Alexander Hanania,2 William MacNee,3 Katja Rüdell,4 Claire Hackford,4 Nihad Tamimi4 1University of Rome ‘Tor Vergata’, Department of Medicine of Systems, Unit of Respiratory Clinical Pharmacology, Rome, Italy; 2Section of Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA; 3University of Edinburgh/MRC Centre for Inflammation Research, The Queen’s Medical Research Institute, Edinburgh, United Kingdom; 4Patient Reported Outcome Center of Excellence, Global Market Access, Primary Care Business Unit, Pfizer, Tadworth, United Kingdom Abstract: Patient-reported outcome (PRO) measures that quantify disease impact have become important measures of outcome in COPD research and treatment. The objective of this literature review was to comprehensively evaluate psychometric properties of available PRO instruments and the ability of each of them to characterize pharmaceutical treatment effects from published clinical trial evidence. Identified in this study were several PRO measures, both those that have been used extensively in COPD clinical trials (St George’s Respiratory Questionnaire and Chronic Respiratory Questionnaire) and new instruments whose full value is still to be determined. This suggests a great need for more information about the patient experience of treatment benefit, but this also may pose challenges to researchers, clinicians, and other important stakeholders (eg, regulatory agencies, pharmaceutical companies) who develop new treatment entities and payers (including but not limited to health technology assessment agencies such as the National Institute for Health and Care Excellence and the Canadian Agency for Drugs and Technologies in Health). The purpose of this review is to enable researchers and clinicians to gain a broad overview of PRO measures in COPD by summarizing the value and purpose of these measures and by providing sufficient detail for interested audiences to determine which instrument may be the most suitable for evaluating a particular research purpose. Keywords: COPD, patient reported outcome, health related quality of life, quality of life, psychometric properties http://www.dovepress.com/a-review-of-the-most-common-patient-reported-outcomes-in-copd-ndash-re-peer-reviewed-article-COPD |
| spellingShingle | Cazzola M Hanania NA MacNee W Rüdell K Hackford C Tamimi N A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges International Journal of COPD |
| title | A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges |
| title_full | A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges |
| title_fullStr | A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges |
| title_full_unstemmed | A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges |
| title_short | A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges |
| title_sort | review of the most common patient reported outcomes in copd ndash revisiting current knowledge and estimating future challenges |
| url | http://www.dovepress.com/a-review-of-the-most-common-patient-reported-outcomes-in-copd-ndash-re-peer-reviewed-article-COPD |
| work_keys_str_mv | AT cazzolam areviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT hananiana areviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT macneew areviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT rudellk areviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT hackfordc areviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT tamimin areviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT cazzolam reviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT hananiana reviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT macneew reviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT rudellk reviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT hackfordc reviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges AT tamimin reviewofthemostcommonpatientreportedoutcomesincopdndashrevisitingcurrentknowledgeandestimatingfuturechallenges |